Ring C-bridged derivatives of thebaine and oripavine.
D000215:Acylation; D000438:Alcohols / Q000494:pharmacology; D000478:Alkylation; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001952:Bridged-Ring Compounds / Q000138:chemical synthesis / Q000494:pharmacology*; D003521:Cyclopropanes / Q000494:pharmacology; D003640:Dealkylation; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D004952:Esters / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D007659:Ketones / Q000494:pharmacology; D051379:Mice; D008968:Molecular Conformation; D009020:Morphine / Q000037:antagonists & inhibitors; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010636:Phenols; D051381:Rats; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013623:Tail; D013797:Thebaine / Q000494:pharmacology*
D000438:Alcohols; D000700:Analgesics; D001952:Bridged-Ring Compounds; D003521:Cyclopropanes; D004952:Esters; D007202:Indicators and Reagents; D007659:Ketones; D009292:Narcotic Antagonists; D010636:Phenols; D013797:Thebaine; D009020:Morphine